Silpak Biswas

2.1k citations
25 papers · 1.6k indexed · 1 hit paper · h-index 19

Impact in

Papers in

Silpak Biswas

25 papers receiving 1.5k citations

Hit Papers

Colistin: an update on the antibiotic of the 21st century 2012 · 450 citations
4502012202620162021100200300400

Peers

Silpak Biswas
Comparison fields: 5 of 112
  • Molecular Medicine 673
  • Endocrinology 279
  • Applied Microbiology and Biotechnology 66
  • Food Science 461
  • Clinical Biochemistry 132
Replace Ingo Stock with:
Ingo Stock Germany
Line Elnif Thomsen Denmark
Olivier Gaillot France
Matthias Willmann Germany
Tariq Ali China
Christine J. Boinett United Kingdom
Sujay Chattopadhyay United States
Rebecca Abraham Australia
Ji Yang Australia
Elizabeth J. Klemm United Kingdom
Silpak Biswas relative to Ingo Stock Germany Ingo Stock's profile →
Citations per field
00.5×2.7×
Ingo Stock · 1×
Citations per year

Countries citing papers authored by Silpak Biswas

Since Specialization
Citations

This map shows the geographic impact of Silpak Biswas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silpak Biswas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silpak Biswas more than expected).

Fields of papers citing papers by Silpak Biswas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silpak Biswas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silpak Biswas. The network helps show where Silpak Biswas may publish in the future.

Co-authors

The 25 scholars most cited alongside Silpak Biswas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Silpak Biswas Line = papers co-authored together Silpak Biswas links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20241
2 202311
3 20229
4 202116
5 202045
6 202037
7 202020
8 202047
9 2019191
10 201612
11 2013120
12
Colistin: an update on the antibiotic of the 21st century
Hit paper breakdown →
2012450
13 2012139
14 200839
15 200841
16 200862
17 200729
18 200643
19 200619
20 200623

About Silpak Biswas

Silpak Biswas is a scholar working on Molecular Medicine, Endocrinology, Parasitology, Food Science and Applied Microbiology and Biotechnology, having authored 25 papers that have together received 1.6k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (12 papers), Salmonella and Campylobacter epidemiology (8 papers), Vibrio bacteria research studies (5 papers), Bartonella species infections research (5 papers), Pharmaceutical and Antibiotic Environmental Impacts (4 papers), Viral Infections and Vectors (3 papers), Yersinia bacterium, plague, ectoparasites research (3 papers) and Bacteriophages and microbial interactions (2 papers). The work is most often cited by research in Molecular Medicine (673 citations), Endocrinology (279 citations), Applied Microbiology and Biotechnology (66 citations), Food Science (461 citations) and Clinical Biochemistry (132 citations). Silpak Biswas has collaborated with scholars based in China, France and India. Frequent co-authors include Jean‐Marc Rolain, Jean Michel Brunel, Martine Reynaud‐Gaubert, J.‐C. Dubus, Min Yue, Mohammed Elbediwi, Didier Raoult, Hang Pan, Weihuan Fang and Xiaoliang Li. Their work appears in journals such as Antibiotics, Frontiers in Microbiology, PLoS Genetics, American Journal of Human Biology and Frontiers in Bioengineering and Biotechnology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026